Assenagon Asset Management S.A. Grows Stock Holdings in CVS Health Corporation $CVS

Assenagon Asset Management S.A. lifted its holdings in CVS Health Corporation (NYSE:CVS) by 14.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,956,013 shares of the pharmacy operator’s stock after acquiring an additional 370,926 shares during the quarter. Assenagon Asset Management S.A. owned 0.23% of CVS Health worth $234,589,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Capital World Investors grew its stake in shares of CVS Health by 2.1% during the 3rd quarter. Capital World Investors now owns 68,382,158 shares of the pharmacy operator’s stock worth $5,155,380,000 after purchasing an additional 1,419,575 shares during the period. State Street Corp lifted its stake in shares of CVS Health by 0.3% in the 3rd quarter. State Street Corp now owns 58,938,286 shares of the pharmacy operator’s stock valued at $4,443,357,000 after purchasing an additional 149,701 shares during the period. Capital International Investors boosted its holdings in CVS Health by 1.1% during the third quarter. Capital International Investors now owns 26,692,203 shares of the pharmacy operator’s stock worth $2,012,347,000 after buying an additional 302,499 shares in the last quarter. Invesco Ltd. boosted its holdings in CVS Health by 3.2% during the third quarter. Invesco Ltd. now owns 24,293,058 shares of the pharmacy operator’s stock worth $1,831,454,000 after buying an additional 760,579 shares in the last quarter. Finally, Norges Bank acquired a new stake in CVS Health during the second quarter valued at $1,358,698,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. UBS Group reiterated an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Piper Sandler restated an “overweight” rating and set a $101.00 target price (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Barclays upped their price target on CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. Morgan Stanley increased their price target on CVS Health from $89.00 to $93.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 10th. Finally, Argus cut their price objective on CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $95.05.

CVS Health Trading Down 0.3%

Shares of CVS Health stock opened at $71.26 on Tuesday. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. CVS Health Corporation has a twelve month low of $58.35 and a twelve month high of $85.15. The firm has a market capitalization of $90.66 billion, a PE ratio of 51.64, a P/E/G ratio of 0.75 and a beta of 0.49. The firm’s 50-day moving average price is $77.30 and its 200 day moving average price is $77.82.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.00 by $0.09. The company had revenue of $105.69 billion during the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.CVS Health’s quarterly revenue was up 8.2% on a year-over-year basis. During the same period in the previous year, the business earned $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, sell-side analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd will be issued a $0.665 dividend. The ex-dividend date is Thursday, April 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.7%. CVS Health’s dividend payout ratio (DPR) is presently 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.